학술논문

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.
Document Type
Article
Source
Vaccines; May2022, Vol. 10 Issue 5, p695-695, 14p
Subject
BREAKTHROUGH infections
COVID-19 vaccines
BOOSTER vaccines
NEUROLOGICAL disorders
MULTIPLE sclerosis
HIV seroconversion
Language
ISSN
2076393X
Abstract
Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)